Ensoma
Clinical trials sponsored by Ensoma, explained in plain language.
-
Gene therapy breakthrough offers hope for rare immune disorder
Disease control Recruiting nowThis study tests a new gene therapy called EN-374 for people with X-linked chronic granulomatous disease (X-CGD), a rare immune disorder that causes severe infections. The therapy uses a modified virus to deliver a working gene to fix the immune cells. The trial aims to see if it…
Phase: PHASE1, PHASE2 • Sponsor: Ensoma • Aim: Disease control
Last updated May 17, 2026 07:33 UTC
-
New study looks at immune system clues in rare disease
Knowledge-focused Recruiting nowThis study is for people with chronic granulomatous disease (CGD), a rare immune disorder. Researchers will measure levels of antibodies against adenovirus and markers of inflammation in the blood. The goal is to better understand the immune system in CGD. About 60 adults and chi…
Sponsor: Ensoma • Aim: Knowledge-focused
Last updated May 15, 2026 12:06 UTC